‘Get it all’ in your first lumpectomy with MarginProbe.
Doctors answer patients' questions about MarginProbe
MarginProbe helps surgeons assess margins in the operating room.
For breast surgeons, there are critical questions with every lumpectomy performed: Did I remove the right amount of tissue? Are the margins clean? Will I be able to tell my patient that we’ve removed all of the cancer? Did I do my job well?
The MarginProbe® System is a new technology to provide surgeons, for the first time, with the ability to perform an intraoperative margin assessment — a diagnostic procedure to better identify whether the tissue excised during the lumpectomy has positive margins. In approximately five minutes, within the operating room, surgeons can now have immediate information about the presence of cancer cells on the margins of the tumor.
Breast surgeons have said that this is the first significant advance in margin assessment in thirty years.
On December 28, 2012, the MarginProbe System received Premarket Approval by the US Food and Drug Administration.
Latest MarginProbe news
September 7, 2016
Dear colleagues, It has been an amazing year thus far for the Dune Medical team. I am excited to share a recap of the highlights and outline what’s to come… Read more
August 23, 2016
PRESS RELEASE (August 23, 2016 – Paoli, PA) Dune Medical Devices has been selected as one of the few recipients of a European Union Horizon 2020 research grant to spur… Read more
August 10, 2016
The MarginProbe system provides breast cancer surgeons with real-time information during lumpectomies to help decide whether additional tissue should be excised. This is intended to reduce the positive margin rate,… Read more